BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home » Authors » Larry Haimovitch

Larry Haimovitch

Articles

ARTICLES

When a deal value deferred by milestones is still a good deal

March 7, 2011
By Larry Haimovitch

CAE vs. CAS heatedly debated by numerous surgeons at ISC meeting

March 1, 2011
By Larry Haimovitch

ISC spotlight is focused on acute ischemic stroke

Feb. 17, 2011
By Larry Haimovitch
LOS ANGELES — The annual International Stroke Conference, (ISC) sponsored by the American Heart Association (AHA; Dallas) was held here last week. One of the key topics was the treatment of an acute ischemic stroke (AIS). (Medical Device Daily)
Read More

CAE vs. CAS heatedly debated at ISC session

Feb. 14, 2011
By Larry Haimovitch
LOS ANGELES — The purpose of a clinical trial, particularly a huge, multi-center, prospective and randomized one, is to provide sufficient data to guide physicians to deliver the best care for their patients. The vast majority of trials, whether device or drug-based, generally achieve this goal. (Medical Device Daily)
Read More

Cardiothoracic surgeons learn of latest surgical innovations

Feb. 1, 2011
By Larry Haimovitch
SAN DIEGO — The 47th annual meeting of the Society of Thoracic Surgeons (STS; Chicago) which is taking place here, was well-attended as cardiothoracic (CT) surgeons gathered to meet and gain up-to-date information on their subspecialty. (Medical Device Daily)
Read More

Private companies whet the appetites of attendees

Jan. 17, 2011
By Larry Haimovitch
SAN FRANCISCO – This annual conference, which in recent years has become the "must go-to" healthcare meeting, offers something for just about everyone's appetite. And, for those of us who are interested in earlier stage, private companies there was a rich menu to choose from.(Medical Device Daily)
Read More

Word on the Street: Despite difficulties, med-tech industry still having success

Jan. 4, 2011
By Larry Haimovitch

Investors' hearts racing at cardio company presentations

Dec. 13, 2010
By Larry Haimovitch

Private med-tech firms see rosy futures in varied spaces

Dec. 7, 2010
By Larry Haimovitch
NEW YORK — The 22nd annual Piper Jaffray (Minneapolis) Health Care Conference took place here last week. As usual, the conference was very well-attended by a wide variety of constituents from the financial community and, as always, featured an exciting roster of both public and private med-tech companies. (Medical Device Daily)
Read More

Recent deals offer hope for beleaguered VC model

Nov. 29, 2010
By Larry Haimovitch
View All Articles by Larry Haimovitch

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 9, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing